Why Vertex Pharmaceuticals Stock Is Getting Hammered Today

why vertex pharmaceuticals stock is getting hammered today

Sumary of Why Vertex Pharmaceuticals Stock Is Getting Hammered Today:

  • The company’s shares fell by as much as 14.5% in pre-market trading Friday morning in response to the biotech’s decision to discontinue the clinical program for VX-864, an experimental treatment for the rare genetic disorder alpha-1 antitrypsin (AATD)..
  • As a result Vertex no longer has a candidate in its clinical pipeline for this potentially lucrative genetic disorder….

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.